Lord, Abbett & Co
NRIX icon

Lord, Abbett & Co’s Nurix Therapeutics NRIX Stock Holding History

Lord, Abbett & Co’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-437,772
Closed -$8.25M – 561
2024
Q4 		$8.25M Buy
437,772
+87,132
+25% +$1.64M 0.03% 406
2024
Q3 		$7.88M Buy
+350,640
New +$7.88M 0.03% 427